curasan AG launched Spinevisc(R), a biomimetic hyaluronic acid with a medium molecular weight similar to the body's own synovial fluids, dedicated for the treatment of the widespread facet syndrome (facet joint arthrosis). curasan will launch Spinevisc(R) during the German Orthopedic and Traumatology Congress (DKOU), to be held between October 22-25 in Berlin, Germany, followed by the Spine Interventional Neuroradiology Symposium of the European Society of Neuroradiology (ESNR), to be held from October 25-27 in Malta.